HOME
PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Mobile
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nadia Harbeck Selected Research
Nadia Harbeck Research Topics
Disease
112
Breast Neoplasms (Breast Cancer)
11/2015 - 01/2002
59
Neoplasms (Cancer)
11/2015 - 01/2002
16
Neoplasm Metastasis (Metastasis)
01/2014 - 01/2002
11
Ovarian Neoplasms (Ovarian Cancer)
08/2012 - 06/2003
9
Carcinoma (Carcinomatosis)
02/2014 - 02/2002
4
Neutropenia
07/2015 - 04/2006
4
Disease Progression
07/2015 - 06/2004
3
Anemia
07/2015 - 03/2009
3
Leukopenia
07/2015 - 01/2010
3
Ascites
03/2007 - 06/2003
2
Alopecia (Baldness)
01/2012 - 07/2009
2
Residual Neoplasm
02/2009 - 03/2007
2
Meningeal Carcinomatosis
09/2008 - 01/2007
1
Fatigue
07/2015
1
Thrombocytopenia (Thrombopenia)
07/2015
1
Aneuploidy (Aneuploid)
04/2015
1
Lobular Carcinoma
02/2014
1
Hearing Loss (Hearing Impairment)
08/2013
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2011
1
Heart Failure
03/2010
1
Nausea
07/2009
Drug/Important Bio-Agent (IBA)
27
Hormones
IBA
11/2015 - 01/2002
20
trastuzumab (Herceptin)
FDA Link
11/2015 - 01/2003
18
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
01/2014 - 01/2002
18
Plasminogen Activator Inhibitor 1
IBA
01/2014 - 01/2002
15
Biological Markers (Surrogate Marker)
IBA
01/2014 - 06/2004
12
Epidermal Growth Factor Receptor (EGF Receptor)
IBA
07/2015 - 12/2009
12
Estrogens (Estrogen)
FDA Link
08/2012 - 11/2003
11
Tissue Extracts
IBA
11/2010 - 01/2002
10
Plasminogen Activators (Plasminogen Activator)
IBA
01/2014 - 01/2002
9
Tamoxifen
FDA Link
Generic
01/2010 - 07/2004
8
Paclitaxel (Taxol)
FDA Link
Generic
11/2015 - 03/2007
8
Epirubicin (Ellence)
FDA Link
Generic
11/2011 - 03/2007
7
Messenger RNA (mRNA)
IBA
05/2014 - 07/2003
7
docetaxel (Taxotere)
FDA Link
03/2013 - 01/2006
6
Progesterone Receptors (Progesterone Receptor)
IBA
08/2012 - 02/2005
6
Antigens
IBA
03/2007 - 08/2002
5
capecitabine (Xeloda)
FDA Link
01/2012 - 08/2005
5
Serine Proteases (Serine Protease)
IBA
10/2010 - 01/2006
5
Biological Factors
IBA
07/2009 - 01/2002
4
taxane
IBA
04/2015 - 01/2008
4
Cyclophosphamide (Cytoxan)
FDA Link
Generic
09/2011 - 11/2009
4
Kallikreins (Kallikrein)
IBA
03/2006 - 06/2003
3
Carbon Monoxide
IBA
11/2015 - 08/2006
3
fulvestrant (Faslodex)
FDA Link
07/2015 - 01/2011
3
pertuzumab
IBA
05/2014 - 03/2013
3
anastrozole (Arimidex)
FDA Link
Generic
05/2013 - 12/2007
3
Taxoids
IBA
03/2013 - 04/2006
3
bevacizumab
FDA Link
01/2011 - 02/2010
3
RNA (Ribonucleic Acid)
IBA
11/2009 - 04/2006
3
Transcription Factors (Transcription Factor)
IBA
10/2009 - 07/2007
3
DNA (Deoxyribonucleic Acid)
IBA
10/2009 - 04/2006
3
Paraffin
IBA
10/2009 - 11/2008
2
gemcitabine
FDA Link
11/2015 - 01/2015
2
Carboplatin (JM8)
FDA Link
Generic
11/2015 - 01/2015
2
Phenobarbital (Luminal)
FDA Link
11/2015 - 12/2013
2
lapatinib (GW572016)
FDA Link
04/2015 - 02/2015
2
N,N'-bis(4-azidobenzoyl)cystine
IBA
02/2014 - 12/2013
2
Diphosphonates
IBA
10/2013 - 04/2010
2
Tyrosine (L-Tyrosine)
FDA Link
09/2013 - 02/2005
2
Aromatase (CYP19)
IBA
05/2013 - 01/2010
2
Platinum
IBA
08/2012 - 03/2007
2
Levonorgestrel (Plan B)
FDA Link
Generic
07/2011 - 11/2010
2
Angiogenesis Inhibitors
IBA
01/2011 - 02/2010
2
Plasminogen
IBA
10/2010 - 03/2007
2
Doxorubicin (Adriamycin)
FDA Link
Generic
03/2010 - 01/2010
2
Methotrexate (Mexate)
FDA Link
Generic
11/2009 - 09/2008
2
Formaldehyde (Formol)
FDA Link
12/2008 - 11/2008
2
letrozole (Femara)
FDA Link
Generic
12/2007 - 01/2007
2
Tissue Kallikreins (Tissue Kallikrein)
IBA
03/2007 - 08/2006
2
Indicators and Reagents (Reagents)
IBA
01/2006 - 11/2004
2
human kallikrein 5
IBA
11/2003 - 07/2003
1
beta-apocarotenoid-14',13'-dioxygenase (ADO)
IBA
11/2015
1
4-iodo-3-nitrobenzamide
IBA
11/2015
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
07/2015
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
04/2015
1
Tissue Inhibitor of Metalloproteinases (TIMP)
IBA
04/2015
1
Tissue Inhibitor of Metalloproteinase-1
IBA
04/2015
1
DNA topoisomerase II alpha
IBA
04/2015
1
130-nm albumin-bound paclitaxel
IBA
01/2015
1
sorafenib (BAY 43-9006)
FDA Link
07/2014
1
Neuregulin-1 (Neuregulin 1)
IBA
01/2014
1
squamous cell of head and neck Carcinoma
IBA
01/2014
1
everolimus
FDA Link
12/2013
1
ibandronic acid (Boniva)
FDA Link
10/2013
1
Antibodies
IBA
03/2013
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
03/2013
1
Cytotoxins
IBA
03/2013
1
sunitinib (Sutent)
FDA Link
05/2010
1
hydrogen sulfite (bisulfite)
IBA
01/2010
1
Y-Box-Binding Protein 1
IBA
12/2009
1
Epoetin Alfa (Epogen)
FDA Link
07/2009
Therapy/Procedure
45
Drug Therapy (Chemotherapy)
11/2015 - 01/2002
19
Adjuvant Chemotherapy
04/2015 - 08/2002
4
Neoadjuvant Therapy
11/2015 - 01/2011
4
Segmental Mastectomy (Lumpectomy)
01/2015 - 05/2006
2
Radiotherapy
01/2015 - 01/2007
2
Heterologous Transplantation (Xenotransplantation)
01/2014 - 08/2012
2
Combination Drug Therapy (Combination Chemotherapy)
01/2010 - 03/2007
1
Radical Mastectomy
06/2012